Subscribe to RSS
DOI: 10.1055/s-0044-1782658
Role of Extracorporeal Membrane Oxygenation in the Treatment of Massive Pulmonary Embolism
Abstract
Massive/high-risk pulmonary embolism (PE) is associated with a 30-day mortality rate of approximately 65%. In searching for strategies that may make a dent on this dismal mortality rate, investigators have, over the last decade, shown renewed interest in the potential beneficial role of venoarterial (V-A) extracorporeal membrane oxygenation (ECMO) in the treatment of patients with high-risk PE. There is a dearth of high-quality evidence regarding the value of ECMO in the treatment of massive PE. Studies examining this issue have generally been retrospective, often single center and frequently with small patient numbers. Moreover, these reported studies are not matched with appropriate controls, and, accordingly, it is difficult to regulate for inherent treatment bias. Not surprisingly, there are no randomized controlled trials examining the value of ECMO in the treatment of massive PE, as such trials would pose formidable feasibility challenges. Over the past several years, there has been increasing support for upfront use of V-A ECMO in the treatment of massive PE, when it is complicated by cardiac arrest. In those patients without cardiac arrest, but who have contraindications for thrombolysis, V-A ECMO combined with anticoagulation may be used to stabilize the patient. If after 3 to 5 days, such patients demonstrate persistent right ventricular dysfunction, embolectomy (either surgical or catheter based) should be performed. Well-designed, multicenter, prospective studies are urgently needed to better define the role of V-A ECMO in the treatment of patients with massive PE.
Keywords
massive pulmonary embolism - ECMO - right ventricular - cardiac arrest - large-bore mechanical thrombectomy - thrombolysis - anticoagulation - extracorporeal life supportPublication History
Article published online:
17 April 2024
© 2024. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.
-
References
- 1 Russell C, Keshavamurthy S, Saha S. Classification and stratification of pulmonary embolisms. Int J Angiol 2022; 31 (03) 162-165
- 2 Polaková E, Veselka J. Management of massive pulmonary embolism. Int J Angiol 2022; 31 (03) 194-197
- 3 Assouline B, Assouline-Reinmann M, Giraud R. et al. Management of high-risk pulmonary embolism: what is the place of extracorporeal membrane oxygenation?. J Clin Med 2022; 11 (16) 4734
- 4 Camporota L. Use of ECMO in massive pulmonary embolism. Paper presented at: 42nd ISICEM International Symposium on Intensive Care & Emergency Medicine; March 23, 2023; Brussels, Belgium. Accessed December 1, 2023 at: https://www.isicem.org/19/Home.asp
- 5 Tohme S, Newman JS, Gasparis C, Manetta F. Massive embolism: knife versus PCI. Int J Angiol 2022; 31 (03) 179-187
- 6 Russell C, Keshavamurthy S. Acute massive and submassive pulmonary embolism: historical considerations/surgical techniques of pulmonary embolectomy/novel applications in donor lungs with pulmonary emboli. Int J Angiol 2022; 31 (03) 188-193
- 7 Kerrigan J, Morse M, Haddad E, Willers E, Ramaiah C. Advances in percutaneous management of pulmonary embolism. Int J Angiol 2022; 31 (03) 203-212
- 8 Giraud R, Laurencet M, Assouline B, De Charrière A, Banfi C, Bendjelid K. Can VA-ECMO be used as an adequate treatment in massive pulmonary embolism?. J Clin Med 2021; 10 (15) 3376
- 9 Kmiec L, Philipp A, Floerchinger B. et al. Extracorporeal membrane oxygenation for massive pulmonary embolism as bridge to therapy. ASAIO J 2020; 66 (02) 146-152
- 10 Patel S, Thulasidasan N, Thomson B. et al. Interventional therapies in acute pulmonary embolus-current trends and future directions. Br J Radiol 2023; 96 (1149): 20221151
- 11 Elder M, Blank N, Shemesh A. et al. Mechanical circulatory support for high-risk pulmonary embolism. Interv Cardiol Clin 2018; 7 (01) 119-128
- 12 Brener MI, Burkoff D. Percutaneous mechanical circulatory support: Impella, intra-aortic balloon counterpulsation, TandemHeart, Extracorporeal Bypass, and right ventricular support devices. In: Moscucci M. ed. Grossman & Baim's Cardiac Catheterization, Angiography and Intervention. Philadelphia: Lippincott Williams & Williams; 2021: 1588-1660
- 13 Guglin M, Zucker MJ, Bazan VM. et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol 2019; 73 (06) 698-716
- 14 Shumacker HB. John Heysham Gibbon, Jr.: September 29, 1903-February 5, 1973. Biogr Mem Natl Acad Sci 1982; 53: 213-247
- 15 Gibbon Jr JH. The development of the heart-lung apparatus. Rev Surg 1970; 27 (04) 231-244
- 16 Gibbon Jr JH. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954; 37 (03) 171-185 , passim
- 17 Bartlett RH, John H. John H Gibbon Jr Lecture. Extracorporeal life support: Gibbon fulfilled. J Am Coll Surg 2014; 218 (03) 317-327
- 18 Davies MJ, Arsiwala SS, Moore HM, Kerr S, Sosnowski AW, Firmin RK. Extracorporeal membrane oxygenation for the treatment of massive pulmonary embolism. Ann Thorac Surg 1995; 60 (06) 1801-1803
- 19 Maggio P, Hemmila M, Haft J, Bartlett R. Extracorporeal life support for massive pulmonary embolism. J Trauma 2007; 62 (03) 570-576
- 20 George B, Parazino M, Omar HR. et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support. Resuscitation 2018; 122: 1-5
- 21 Ghoreishi M, DiChiacchio L, Pasrija C. et al. Predictors of recovery in patients supported with venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism. Ann Thorac Surg 2020; 110 (01) 70-75
- 22 Meneveau N, Guillon B, Planquette B. et al. Outcomes after extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases. Eur Heart J 2018; 39 (47) 4196-4204
- 23 Kaso ER, Pan JA, Salerno M. et al. Venoarterial extracorporeal membrane oxygenation for acute massive pulmonary embolism: a meta-analysis and call to action. J Cardiovasc Transl Res 2022; 15 (02) 258-267
- 24 Karami M, Mandigers L, Miranda DDR. et al; DUTCH ECLS Study Group. Survival of patients with acute pulmonary embolism treated with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care 2021; 64: 245-254
- 25 Hobohm L, Sagoschen I, Habertheuer A. et al. Clinical use and outcome of extracorporeal membrane oxygenation in patients with pulmonary embolism. Resuscitation 2022; 170: 285-292
- 26 Konstantinides SV, Meyer G, Becattini C. et al. The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J 2019; 54: 1901647
- 27 Vedantham S. Massive pulmonary embolism: optimizing collaborative care and endovascular therapy. Circ Cardiovasc Interv 2023; 16 (10) e013536
- 28 Silver MJ, Gibson CM, Giri J. et al. Outcomes in high-risk pulmonary embolism patients undergoing FlowTriever mechanical thrombectomy or other contemporary therapies: results from the FLAME study. Circ Cardiovasc Interv 2023; 16 (10) e013406
- 29 Glazier JJ, Patiño-Velasquez S, Oviedo C. The Pulmonary Embolism Response Team: rationale, operation, and outcomes. Int J Angiol 2022; 31 (03) 198-202